Skip to main navigation Skip to search Skip to main content

Molecular genetic and clinical delineation of 22 patients with congenital hypogonadotropic hypogonadism

  • Kohei Aoyama
  • , Haruo Mizuno
  • , Tatsushi Tanaka
  • , Takao Togawa
  • , Yutaka Negishi
  • , Kei Ohashi
  • , Ikumi Hori
  • , Masako Izawa
  • , Takashi Hamajima
  • , Shinji Saitoh

Research output: Contribution to journalArticlepeer-review

Abstract

Congenital hypogonadotropic hypogonadism (CHH) is classified as Kallmann syndrome (KS) with anosmia/hyposmia or normosmic (n)CHH. Here, we investigated the genetic causes and phenotype-genotype correlations in Japanese patients with CHH. We enrolled 22 Japanese patients with CHH from 21 families (18 patients with KS and 4 with nCHH) and analyzed 27 genes implicated in CHH by next-generation and Sanger sequencing. We detected 12 potentially pathogenic mutations in 11 families, with three having a mutation in ANOS1 (X-linked recessive); three and four having a mutation in FGFR1 and CHD7, respectively (autosomal dominant); and one having two TACR3 mutations (autosomal recessive). Among four patients with KS carrying a CHD7 mutation, one had perceptive deafness and two had a cleft lip/palate. The frequency of CHH genes in the Japanese was compatible with previous reports, except that CHD7 mutations might be more common. Furthermore, partial phenotype-genotype correlations were demonstrated in our cohort.

Original languageEnglish
Pages (from-to)1111-1118
Number of pages8
JournalJournal of Pediatric Endocrinology and Metabolism
Volume30
Issue number10
DOIs
Publication statusPublished - 26-10-2017
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Fingerprint

Dive into the research topics of 'Molecular genetic and clinical delineation of 22 patients with congenital hypogonadotropic hypogonadism'. Together they form a unique fingerprint.

Cite this